Kuo Bianchini Tong is a Managing Director in the Life Science Practice of Navigant. He joined the firm in November of 2017 to lead up a team dedicated to market access engagements. Kuo works with commercial stage companies to develop comprehensive market access strategies and is known for his work with disruptive technologies that have unique form factors, novel routes of delivery, policy and market access challenges, across all settings of care. Kuo also works with companies in earlier stages of development to raise funds and ensuring that product R&D and clinical activities align and support optimal pricing, reimbursement, and market access. Prior to joining Navigant, Kuo was the CEO of Quorum Consulting, Inc. headquartered in San Francisco, CA for 21 years. During that time, Quorum was a leading firm representing clients with the Centers for Medicare & Medicaid Services (CMS); BCBS, commercial and managed care plans; and other payers and health care delivery systems in solving policy and market access issues. Prior to founding Quorum, Kuo was a Senior Associate at Health Technology Associates (now known as Covance) located in Washington, DC. Prior to entering the consulting field, Kuo as active in clinical and health services research at the University of Pennsylvania School of Medicine and the University of California, Los Angeles Neuropsychiatric Institute. Kuo received his master’s degree from the Johns Hopkins University and his bachelor’s degree from the University of Pennsylvania.